Management of advanced renal cancer.
Atkins
Michael B
MB
Division of Hematology/Oncology, Harvard Medical School, Beth Israel Deaconess Medical Center, and Dana Farber/Harvard Cancer Center, Boston, Massachusetts 02215, USA. matkins@bidmc.harvard.edu
D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D007370:Interferon Type I / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D011994:Recombinant Proteins
D007370:Interferon Type I; D007376:Interleukin-2; D011994:Recombinant Proteins